ERBB2 and neoplasm: As HER-2 is expressed at much higher levels in certain tumours (Figure 3) than in normal tissue and plays a key role in mitogenic and antiapoptotic signalling [7, 12, 20], it was recognised as an ideal target for anticancer drugs.